Discussion on Relevance and Studies of Prescription Compatibility in Chinese Medicine

Loh Cheng Toa Steven; Goh Xin Yi

doi:10.1007/s11655-020-3217-1

Your Location：

Home >

Browse articles >

Discussion on Relevance and Studies of Prescription Compatibility in Chinese Medicine

Academic Exploration | Updated：2021-10-18

- Discussion on Relevance and Studies of Prescription Compatibility in Chinese Medicine
- Discussion on Relevance and Studies of Prescription Compatibility in Chinese Medicine
- Chinese Journal of Integrative Medicine 2021年27卷第10期页码：788-793
- Affiliations：
  
  NTU Chinese Medicine Clinic, Nanyang Technological University, Singapore (637551)
- Author bio：
  
  Dr. Goh Xin Yi, E-mail: stevenloh@ntu.edu.sg, gohxy@ntu.edu.sg
- Funds：
- DOI：10.1007/s11655-020-3217-1
  中图分类号：
- 纸质出版日期：2021-10-01，
  
  网络出版日期：2020-07-27，
  
  录用日期：2019-06-30
Scan for full text
Loh Cheng Toa Steven, Goh Xin Yi. Discussion on Relevance and Studies of Prescription Compatibility in Chinese Medicine[J]. Chinese Journal of Integrative Medicine, 2021,27(10):788-793.

Loh Cheng Toa Steven, Goh Xin Yi. Discussion on Relevance and Studies of Prescription Compatibility in Chinese Medicine[J]. Chinese Journal of Integrative Medicine, 2021,27(10):788-793.
Loh Cheng Toa Steven, Goh Xin Yi. Discussion on Relevance and Studies of Prescription Compatibility in Chinese Medicine[J]. Chinese Journal of Integrative Medicine, 2021,27(10):788-793. DOI： 10.1007/s11655-020-3217-1.

Loh Cheng Toa Steven, Goh Xin Yi. Discussion on Relevance and Studies of Prescription Compatibility in Chinese Medicine[J]. Chinese Journal of Integrative Medicine, 2021,27(10):788-793. DOI： 10.1007/s11655-020-3217-1.

摘要

Abstract

With Chinese medicine (CM) gaining popularity in recent years

researchers and clinicians have put in much interest and effort into the makings and effects of it

especially after the recent announcement of World Health Orgnitation's incorporation of CM into mainstream medical compendium. Individual herb has complex properties

coming from its pharmacological properties and the Chinese medical principles of organ-directed

taste and dynamic orientational behaviours. The use of individual herb in CM is rare

where various herbs/ingredients are mostly found in a prescribed formula. To fully reveal the effects of CM is a great challenge. The complexity of various herbs in combined effect

the absorption and utility rate by the body

uniqueness of individual physique

sub-types of pathological behaviors and time-line progression of the healing process add on to the complication of understanding the full effect of CM. Various theories such as pathophysiology guidance

pharmacokineticpharmacodynamic compatibility method

and Global Systems Biology for Integrative Genomics

Proteomics and Metabolomics

which interactively provide a wider scope

more details

with the consideration of development timeline

may shed more light to revealing the full picture of the effects of compatibility prescription.

关键词

Keywords

Chinese medicineintegrative effectsmethodologiesprescription compatibility

references

Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med 2011;17:1217.

Cyranoski D. The big push for Chinese medicine. Nature 2018:448-450.

Deng ZJ, ed. Traditional Chinese medicine Formulary. 3rd ed. Beijing:China Press of Traditional Chinese Medicine; 2012;03:10-13

Chen JP, Wu WK, Zhang MS, Tang TJ, Han F. Study on the ideology and methodology of the compatibility of traditional Chinese medicine compound. Chin J Exp Tradit Med Formul (Chin) 2000;1:1-4.

Deng ZY, Wang MJ, Zhang JQ, Luo GP, Chen Y, Zeng JY, et al. An Cough formulae compatibility qualitative and quantitative research.Shandong J Tradit Chin Med (Chin) 2018;37:456-459, 493.

Mao ZP, Liu HN, Xiong YX, Mo XZ, Qi CC. Data analysis study of usage of formulae compatibility. J Jiangxi Univ Tradit Chin Med(Chin) 2017;29:118-121.

Li Z, Rong YY, Wang SM, Wu CW. Formulae compatibility study.Chin J Exp Tradit Med Formul (Chin) 2015;21:223-226.

Gao XM, ed. Chinese materia medica. 1st ed. Beijing: China Press of Traditional Chinese Medicine; 2002:21-43.

Fan FJ, Hong WX, Song JL, Li SX, Zheng CF. Discovery and research on the formulae visualization compatibility. Chin J Biomed Eng (Chin) 2016;35:764-768.

Fan DM, Huang YQ. Current research on formulae compatibility.Strait Pharm J (Chin) 2018;30:20-23.

Zhang Y, Xie YM. Genetics analysis of Chinese herbal medicine.Chin Arch Tradit Chin Med (Chin) 2001;5:426-427.

Deng ZJ, ed. TCM formulary. 1st ed. Beijing: China Press of Traditional Chinese Medicine; 2003:17-19

Wang XJ. Metabonomics study on Chuan Lian Zi toxicity and compatibility. Hefei: Anhui Medical University, 2011.

Ni JX, Lin YH, Chen MZ. Pharmacokinetics analysis of the compatibility of Zuojin Pill. China Mod Med (Chin) 2011;19:19-20.

Zhong XY, Huo WZ, Gong Q, Peng QT, Zhang XF, Zhu SS.Research status of pharmacokinetics of traditional Chinese medicine compatibility. Chin Herb Med (Chin) 2013;44:3084-3088.

Wu JF. Formulae compatibility modern scientific research. J Liaoning Coll Tradit Chin Med (Chin) 2014;16:217-219.

Sato Y, Suzuki I, Nakamura T, Bernier F, Aoshima K, Oda Y.Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology. J Lipid Res 2012;53:567-576.

Huang Z, Lin L, Gao Y, Chen Y, Yan X, Xing J, et al. Bladder cancer determination via two urinary metabolites: a biomarker pattern approach. Mol Cell Proteom 2011;10:M111.007922-M111.

Roberts MJ, Schirra HJ, Lavin MF, Gardiner RA. Metabolomics: a novel approach to early and noninvasive prostate cancer detection.Ko Urol 2011;52:79-89.

Patti GJ, Yanes O, Shriver LP, Courade JP, Tautenhahn R,Manchester M, et al. Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin. Nat Chem Biol 2012;8:232.

Brockmöller SF, Bucher E, Müller BM, Budczies J, Hilvo M, Griffin JL, et al. Integration of metabolomics and expression of glycerol-3-phosphate acyltransferase (GPAM) in breast cancer—link to patient survival, hormone receptor status, and metabolic profiling. J Proteome Res 2012;11:850-860.

Kaddurah-Daouk R, Kristal BS, Weinshilboum RM. Metabolomics:a global biochemical approach to drug response and disease. Ann Rev Pharmacol Toxicol 2008;48:653-683.

Zhou L, Wang Q, Yin P, Xing W, Wu Z, Chen S, et al. Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases. Anal Bioanal Chem 2012;403:203-213.

Patterson AD, Maurhofer O, Beyoǧlu D, Lanz C, Krausz KW, Pabst T, et al. Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling. Cancer Res 2011;71:6590-6000.

Rhee EP, Gerszten RE. Metabolomics and cardiovascular biomarker discovery. Clin Chem 2012;58:139-147.

Leslie RD, Beyan H. Metabolomics makes a mark: early changes associated with autoimmune diabetes. Diabetes 2011;60:2688-2690.

Liu CF, Wang N, Liu SM, Huang ZX, Zu JX, Li JH. Metabolomics sudy of Huanglian Jiedu Tang on fever syndrome. J Shandong Univ Tradit Chin Med (Chin) 2011;35:60-63.

Zhao Y, Su W, Zhang QY, Li BT, Xu GL, Liu HN. Effects of Erzhi Pill on urine metabolites in naturally aging mice. Pharmacol Clin Chin Mater Med (Chin) 2011;27:3-5.

Qu HH, Zhao Y, Wang QG. Compound compatibility mechanism based on Chinese medicine moelecular monoclonal antibodies.Chin J Integr Tradit West Med (Chin) 2012;32:1416-1419.

Wang XJ, Zhang BL. Drug metabolomics and scientific compatibility of prescriptions compatibility. China J Chin Mater Med (Chin)2010;35:1346-1348.

Xu YT. Modern scientific study of formulae compatibility. Chin Herb Med (Chin) 2015;46:465-469.

Wang ZG, Hu HL, Lan K, Jiang XH. Study on the compatibility of traditional Chinese medicine compounds based on pharmacodynamics-pharmacokinetics method based on metabolomics and prescription theory. Chin Herb Med (Chin) 2009;40:169-172.

Luo GA, Liang QL, Liu QF, Zhang RL, Yang HH, Li X, et al. Integrating chemical systemic study of systemic biology—study on Chinese herbal compatibility and mechanism of Chinese medicine compounds. Modern Tradit Chin Med Mater Med-World Sci Technol(Chin) 2007: 10-15,24.

Hood L, Tian Q. Systems approaches to biology and disease enable translational systems medicine. Genom Proteom Bioinform.2012;10:181-185.

Hood L. Systems biology: integrating technology, biology, and computation. Mechan Age Develop 2003;124:9-16.

Nicholson JK, Wilson ID. Understanding 'global' systems biology:metabonomics and the continuum of metabolism. Nat Rev Drug Disc 2003;2:668.

Nicholson J. Global systems biology, personalized medicine and molecular epidemiology Mol Syst Biol 2006:52

Li YP, He LS, Zhao Y, Wang L, Cao X, Deng JG. Study status and new thoughts on Chinese materia medica formula used for AIDS treatment. Chin Herb Med (Chin) 2014;45:303-307.

Xiong F, Jiang M, Huang Z, Chen M, Chen K, Zhou J, et al. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells. Integr Cancer Ther 2013;13:152-160.

Ren LP, Zhang XQ. Guipi Decoction and Guilu Erxian Decoction on the treatment of breast cancer post chemotherapy myelosuppression 50 cases. Shanxi J Tradit Chin Med (Chin) 2009;30:794-795.

Ma XX, Li YB. Data analysis of treatment of diabetes using Chinese herbal compatibility. West J Tradit Chin Med (Chin) 2015;28:100-103.

Wang CF. Usage and clinical study of Xiaoke Pill treatment on qi-yin deficiency syndrome of type Ⅱ diabetes. Diabet New World (Chin)2018;21:73-74.

Zeng ZH, Li HN, Chen GL. Observation on the effect of Xiaoke Pill on qi-yin deficiency syndrome of type 2 diabetes. Diabet New World(Chin) 2013;9:59-60.

Liu Q, Lu C, Zhang WD, Liu RH. Research progress on Shexiang Baoxin Pill. Chin Herb Med (Chin) 2016;47:1409-1417.

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Chemical Composition, Pharmacological Effects and Clinical Applications of Cinobufacini

Immunomodulatory Function of Pien Tze Huang in T Cell-Mediated Anti-tumor Activity against B16-F10, MC38 and Hep1-6 Tumor Models

Safflower Yellow Inhibits Progression of Hepatocellular Carcinoma by Modulating Immunological Tolerance via FAK Pathway

Immunoregulatory and Anti-cancer Activities of Combination Treatment of Novel Four-Herb Formula and Doxorubicin in 4T1-Breast Cancer Bearing Mice

TRAIL and Celastrol Combinational Treatment Suppresses Proliferation, Migration, and Invasion of Human Glioblastoma Cells via Targeting Wnt/β-Catenin Signaling Pathway